164 related articles for article (PubMed ID: 2854901)
21. Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate.
Romero GA; Guerra MV; Paes MG; Macêdo VO
Am J Trop Med Hyg; 2001 Nov; 65(5):456-65. PubMed ID: 11716098
[TBL] [Abstract][Full Text] [Related]
22. [Sporotrichoid cutaneous leishmaniasis].
López-Escobar M; Drake-Monfort M; Salesa-Gutiérrez de Rozas R; Hermana-Ramírez S
Actas Dermosifiliogr; 2007; 98(6):444-5. PubMed ID: 17663940
[No Abstract] [Full Text] [Related]
23. Intralesional glucantime in Leishmania braziliensis braziliensis infections.
Barrios LA; Costa JM; Netto EM; Vexenat CO; Cuba CC; Marsden PD
Trans R Soc Trop Med Hyg; 1986; 80(1):173-4. PubMed ID: 3726989
[No Abstract] [Full Text] [Related]
24. [Treatment of visceral leishmaniasis in children].
Minodier P; Noël G; Blanc P; Uters M; Retornaz K; Garnier JM
Med Trop (Mars); 2007 Feb; 67(1):73-8. PubMed ID: 17506279
[TBL] [Abstract][Full Text] [Related]
25. A strange infiltrative plaque on the face.
Guarneri C; Wollina U; Chokoeva A; Lotti TM; Tchernev G
Braz J Infect Dis; 2016; 20(2):214-5. PubMed ID: 26748228
[No Abstract] [Full Text] [Related]
26. Failure of meglumine antimoniate to cure cutaneous lesions due to Leishmania major in Algeria.
Belazzoug S; Neal RA
Trans R Soc Trop Med Hyg; 1986; 80(4):670-1. PubMed ID: 3544363
[No Abstract] [Full Text] [Related]
27. [Renal function in patients with mucocutaneous leishmaniasis treated with pentavalent antimony compounds].
Veiga JP; Rosa TT; Kimachi T; Wolff ER; Sampaio RN; Gagliardi AR; Junqueira Júnior LF; Costa JM; Marsden PD
Rev Inst Med Trop Sao Paulo; 1985; 27(6):298-302. PubMed ID: 3014634
[No Abstract] [Full Text] [Related]
28. Personal experience with diagnostic and therapeutic aspects of human Leishmania (Viannia) braziliensis in Três Braços.
Marsden PD
Mem Inst Oswaldo Cruz; 1994; 89(3):485-7. PubMed ID: 7476237
[TBL] [Abstract][Full Text] [Related]
29. [Slowly progressing skin ulcers following a stay in Costa Rica].
Mateo M; Cruz I; Flores MD; López-Vélez R
Enferm Infecc Microbiol Clin; 2005 Apr; 23(4):243-4. PubMed ID: 15826551
[No Abstract] [Full Text] [Related]
30. Recurrences of tegumentary leishmaniasis.
Weigle KA; Valderrama L; Santrich C; Saravia NG
Lancet; 1985 Sep; 2(8454):557-8. PubMed ID: 2863579
[No Abstract] [Full Text] [Related]
31. [Visceral leishmaniasis: new drugs].
Minodier P; Robert S; Retornaz K; Garnier JM
Arch Pediatr; 2003 Dec; 10 Suppl 5():550s-556s. PubMed ID: 15022780
[TBL] [Abstract][Full Text] [Related]
32. [Xenodiagnosis using Lutzomyia youngi in Venezuelan cases of cutaneous leishmaniasis due to Leishmania braziliensis].
Rojas E; Scorza JV
Mem Inst Oswaldo Cruz; 1989; 84(1):29-34. PubMed ID: 2319949
[TBL] [Abstract][Full Text] [Related]
33. Disseminated cutaneous leishmaniasis caused by Leishmania braziliensis in Southern Brazil.
Membrive NA; Kazuma FJ; Silveira TGV; Teixeira JJV; Reinhold-Castro KR; Teodoro U
Rev Inst Med Trop Sao Paulo; 2017 Jun; 59():e37. PubMed ID: 28591265
[TBL] [Abstract][Full Text] [Related]
34. Atypical manifestations of tegumentary leishmaniasis in a transmission area of Leishmania braziliensis in the state of Bahia, Brazil.
Guimarães LH; Machado PR; Lago EL; Morgan DJ; Schriefer A; Bacellar O; Carvalho EM
Trans R Soc Trop Med Hyg; 2009 Jul; 103(7):712-5. PubMed ID: 19481233
[TBL] [Abstract][Full Text] [Related]
35. Meglumine antimoniate is more effective than sodium stibogluconate in the treatment of cutaneous leishmaniasis.
Yesilova Y; Surucu HA; Ardic N; Aksoy M; Yesilova A; Oghumu S; Satoskar AR
J Dermatolog Treat; 2016; 27(1):83-7. PubMed ID: 26105204
[TBL] [Abstract][Full Text] [Related]
36. Genotypic profiles of Leishmania (Viannia) braziliensis strains from cutaneous leishmaniasis patients and their relationship with the response to meglumine antimoniate treatment: a pilot study.
Gagini T; de Oliveira Schubach A; de Fatima Madeira M; Maria Valete-Rosalino C; Fernandes Pimentel MI; da Silva Pacheco R
Parasite; 2017; 24():34. PubMed ID: 28959938
[TBL] [Abstract][Full Text] [Related]
37. Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients.
Ribera E; Ocaña I; de Otero J; Cortes E; Gasser I; Pahissa A
Am J Med; 1996 May; 100(5):496-501. PubMed ID: 8644760
[TBL] [Abstract][Full Text] [Related]
38. Effects of antimonial therapy for canine leishmaniasis on antibody titer.
Amusategui I; Sainz A; Tesouro MA
Ann N Y Acad Sci; 1998 Jun; 849():444-6. PubMed ID: 9668509
[No Abstract] [Full Text] [Related]
39. Two small yellowish papules in a 1 year-old boy: cutaneous leishmaniasis.
Noguera-Morel L; Azorin D; Xirotagaros G
Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136631
[TBL] [Abstract][Full Text] [Related]
40. Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1.
Mandal G; Mandal S; Sharma M; Charret KS; Papadopoulou B; Bhattacharjee H; Mukhopadhyay R
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003500. PubMed ID: 25714343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
